Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+5.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,007
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| 1 |
ConocoPhillips
COP
|
+$230M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$185M |
| 3 |
WESCO International
WCC
|
+$171M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Delta Air Lines
DAL
|
+$148M |
Top Sells
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$221M |
| 2 |
3M
MMM
|
+$154M |
| 3 |
Marsh & McLennan
MMC
|
+$115M |
| 4 |
Johnson & Johnson
JNJ
|
+$99M |
| 5 |
Novo Nordisk
NVO
|
+$94.6M |
Sector Composition
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Astera Labs
ALAB
$35.7B
| $6.81M | 0.01% |
51,432
-608,923
| -92% | -$80.7M |
|
677
Pultegroup
PHM
$27B
| $6.71M | 0.01% |
61,600
+11,000
| +22% | +$1.2M |
|
678
Caesars Entertainment
CZR
$5.28B
| $6.63M | 0.01% |
198,500
-5,400
| -3% | -$180K |
|
679
Arcus Biosciences
RCUS
$1.2B
| $6.6M | 0.01% |
+443,000
| New | +$6.6M |
|
680
Epsilon Energy
EPSN
$122M
| $6.59M | 0.01% |
1,061,909
| – | – |
|
681
Travere Therapeutics
TVTX
$1.93B
| $6.56M | 0.01% |
376,800
-23,200
| -6% | -$404K |
|
682
BrightSpring Health Services
BTSG
$4.65B
| $6.53M | 0.01% |
383,377
-581,153
| -60% | -$9.9M |
|
683
Savara
SVRA
$660M
| $6.5M | 0.01% |
2,115,771
-4,637,930
| -69% | -$14.2M |
|
684
Brown-Forman Class B
BF.B
$13B
| $6.46M | 0.01% |
170,132
-2,700
| -2% | -$103K |
|
685
Viatris
VTRS
$12.2B
| $6.43M | 0.01% |
+516,364
| New | +$6.43M |
|
686
Edgewise Therapeutics
EWTX
$1.55B
| $6.41M | 0.01% |
240,000
+218,491
| +1,016% | +$5.83M |
|
687
Astria Therapeutics
ATXS
$425M
| $6.38M | 0.01% |
713,200
-54,743
| -7% | -$489K |
|
|
INGM
688
Ingram Micro Holding Corporation
INGM
$4.8B
| $6.3M | 0.01% |
+325,000
| New | +$6.3M |
|
689
Nabors Industries
NBR
$587M
| $6.29M | 0.01% |
110,000
-15,000
| -12% | -$858K |
|
690
Corbus Pharmaceuticals
CRBP
$117M
| $6.24M | 0.01% |
528,937
| – | – |
|
691
Equity Residential
EQR
$25.4B
| $6.23M | 0.01% |
+86,882
| New | +$6.23M |
|
692
Mirum Pharmaceuticals
MIRM
$3.9B
| $6.2M | 0.01% |
150,000
+70,000
| +88% | +$2.89M |
|
693
Madrigal Pharmaceuticals
MDGL
$10B
| $6.16M | 0.01% |
+19,960
| New | +$6.16M |
|
694
NovoCure
NVCR
$1.42B
| $5.96M | 0.01% |
+200,000
| New | +$5.96M |
|
695
Equitable Holdings
EQH
$15.8B
| $5.9M | 0.01% |
125,000
+25,000
| +25% | +$1.18M |
|
696
Ivanhoe Electric
IE
$1.18B
| $5.84M | 0.01% |
772,890
-123,088
| -14% | -$929K |
|
697
Mohawk Industries
MHK
$8.42B
| $5.83M | 0.01% |
48,970
+29,600
| +153% | +$3.53M |
|
698
Relay Therapeutics
RLAY
$702M
| $5.77M | 0.01% |
1,400,000
-250,000
| -15% | -$1.03M |
|
699
Camden Property Trust
CPT
$11.9B
| $5.77M | 0.01% |
49,700
-13,300
| -21% | -$1.54M |
|
|
CLDT
700
Chatham Lodging
CLDT
$350M
| $5.74M | 0.01% |
+641,087
| New | +$5.74M |
|